Palvella Therapeutics (PVLA) Receivables - Other (2019 - 2024)

Palvella Therapeutics (PVLA) has 4 years of Receivables - Other data on file, last reported at $3.0 million in Q2 2024.

• Quarterly Receivables - Other changed N/A year-over-year to $3.0 million in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $3.0 million (changed N/A YoY) and the FY2023 annual result came in at $2.3 million, down 51.25% from the prior year.
• Receivables - Other declined to $3.0 million in Q2 2024 per PVLA's latest filing, from $3.1 million in the prior quarter.
• Across five years, Receivables - Other topped out at $4.8 million in Q4 2022 and bottomed at $2.3 million in Q4 2023.
• The 3-year median for Receivables - Other is $3.1 million (2024), against an average of $3.3 million.
• Peak annual rise in Receivables - Other reached 51.25% in 2023, while the deepest fall reached 51.25% in 2023.
• Tracing PVLA's Receivables - Other over 3 years: stood at $4.8 million in 2022, then plunged by 51.25% to $2.3 million in 2023, then soared by 31.08% to $3.0 million in 2024.
• Per Business Quant, the three latest PVLA Receivables - Other figures stand at $3.0 million (Q2 2024), $3.1 million (Q1 2024), and $2.3 million (Q4 2023).

Peer Comparison